ACE2 and carcinoma: We identified 48 clinically approved anti‐HT drugs that were tested on the same four carcinoma cell lines for up to 24 h in CMAP and computed the ACE2 expression changes after their treatment averaged across the cell lines (Materials and Methods; the cell lines are A549, MCF7, PC3, and VCAP, selected because of the data available for a high number of drugs tested on all these cells, see Appendix Note S1, Appendix Fig S1 and Table EV1A for details).